CypD-mediated mitochondrial dysfunction contributes to titanium ion-induced MC3T3-E1 cell injury

Area of Science:

• Biomaterials Science
• Cell Biology
• Orthopedics

Background:

• Titanium (Ti) ions are implicated in aseptic loosening of implants due to potential osteoblast apoptosis.
• Mitochondrial dysfunction is linked to osteoblast dysfunction, but the precise mechanism of Ti ion-induced apoptosis remains unclear.

Purpose of the Study:

• To investigate the role of mitochondrial oxidative stress (mtROS) in Ti ion-induced apoptosis of osteoblastic cells.
• To elucidate the molecular mechanisms underlying Ti ion-induced mitochondrial dysfunction and osteoblast apoptosis.

Main Methods:

• In vitro study using murine MC3T3-E1 osteoblastic cells exposed to Ti ions.
• Assessment of mitochondrial membrane potential (MMP), adenosine triphosphate (ATP) production, and mtROS levels.
• Evaluation of the effects of mitoquinone (MitoQ) and cyclosporin A (CsA), a cyclophilin D (CypD) inhibitor.

Main Results:

• Ti ions reduced MMP and ATP production while increasing mtROS, indicating mitochondrial dysfunction.
• Mitochondrial abnormalities significantly contributed to Ti ion-induced osteoblast apoptosis.
• MitoQ alleviated Ti ion-induced mitochondrial dysfunction and apoptosis; CypD overexpression exacerbated apoptosis, while CsA treatment rescued these effects.

Conclusions:

• Ti ions induce osteoblast apoptosis primarily through mtROS-mediated mitochondrial dysfunction involving cyclophilin D (CypD).
• CypD plays a critical role in Ti ion-induced mitochondrial dysfunction and osteoblast apoptosis.
• CypD inhibitors like CsA demonstrate protective effects, suggesting potential therapeutic applications for preventing implant failure.